[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349725-105":59,"doc-detail-349725-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","systematic-evaluation-of-a-novel-mesoporous-silica-nanoparticles-msns-spirulina-platensis-nanohybrid-for-breast-cancer-treatment-mechanistic-investigation-via-pharmacological-network-analysis","Systematic evaluation of a novel mesoporous silica nanoparticles (MSNs)-Spirulina platensis nanohybrid for breast cancer treatment: mechanistic investigation via pharmacological network analysis","","Breast cancer remains highly lethal for women worldwide, motivating the search for safer, more effective therapies. This study integrates network pharmacology with nanoscience to identify multi-target pharmacological actions of Spirulina platensis bioactives and improve stability and anticancer efficacy using mesoporous silica nanoparticles (MSNs). Network analysis highlights AKT1, SRC, IGFR1, BCL-2, and EGFR as core targets linked to microRNA enrichment, PI3K-Akt signaling, and EGFR inhibitor resistance pathways. A nanohybrid (SP@MSNs) was characterized by SEM, TEM, EDX, XRD, FTIR, BET, zeta potential, and TGA, then tested on normal and breast cancer cells using MTT. The biocompatible composite showed optimized physicochemical properties and high loading capacity (LC 78.07%) and encapsulation efficiency (EE 98.37%), with SP@MSNs enhancing antibreast cancer activity 3.5-fold versus Spirulina extract alone. ",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-evaluation-of-a-novel-mesoporous-silica-nanoparticles-msns-spirulina-platensis-nanohybrid-for-breast-cancer-treatment-mechanistic-investigation-via-pharmacological-network-analysis/349725/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-evaluation-of-a-novel-mesoporous-silica-nanoparticles-msns-spirulina-platensis-nanohybrid-for-breast-cancer-treatment-mechanistic-investigation-via-pharmacological-network-analysis/349725.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study?","Question",{"text":112,"@type":113},"To systematically evaluate a mesoporous silica nanoparticle (MSNs)-Spirulina platensis nanohybrid for breast cancer treatment, including mechanistic investigation using pharmacological network analysis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which core target genes were identified through network pharmacology?",{"text":117,"@type":113},"AKT1, SRC, IGFR1, BCL-2, and EGFR were highlighted as core target genes associated with relevant cancer pathways and multi-wave mechanisms of Spirulina compounds.",{"name":119,"@type":110,"acceptedAnswer":120},"How was the SP@MSNs nanohybrid prepared and characterized?",{"text":121,"@type":113},"SP@MSNs was formulated as a nanohybrid platform and characterized using structural and morphological analyses including SEM, TEM, EDX, XRD, FTIR, BET, zeta size/potential, and TGA.",{"name":123,"@type":110,"acceptedAnswer":124},"How did SP@MSNs perform compared with Spirulina extract alone?",{"text":125,"@type":113},"SP@MSNs increased antibreast cancer activity by about 3.5-fold, with an IC50 value of 33.6 ± 0.32 mg mL−1, while MSNs improved stability, solubility, and cellular uptake.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},349725,1790726643,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":36,"preview_page_count":19,"preview_urls":149},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","RSC Advances  \nPAPER  \nCite this: RSC Adv., 2026, 16, 4347  \nReceived 17th November 2025  \nAccepted 1st January 2026 DOI: 10.1039/d5ra08876c[rsc.li/rsc-advances](rsc.li/rsc-advances)  \nSystematic evaluation of a novel mesoporous silica nanoparticles (MSNs)-Spirulina platensis nanohybrid for breast cancer treatment:  \nmechanistic investigation via pharmacological network analysis  \nDina S. Ghallab,  *a Doaa A. Ghareeb,bcd Mazen Sherif b and Marwa Y. Kenawye  \nBreast cancer continues to be one of the world's most deadly diseases among women, with a high incidence rate. Thus, searching for safe and eﬀective treatment is urgently needed. Spirulina platensis, which is packed with an astonishing variety of bioactive compounds, may present a decent option against this crippling disorder. Accordingly, the current work innovatively integrated network pharmacology and nanoscience to pinpoint multi-target pharmacological eﬀects of Spirulina bioactivesand enhance their stability and anticancer eﬀectiveness via a mesoporous silica nanoparticles (MSNs) framework. Network pharmacology analysis illuminated AKT1, SRC, IGFR 1, BCL-2, and EGFR as the core target genes that are typically enriched in microRNAs in cancer, PI3K-Akt signaling, and EGFR tyrosine kinase inhibitor resistance pathways, and they are associated with the multi-wave mechanism of Spirulina compounds against breast cancer. Complementarily, a nanohybrid platform of MSNs and Spirulina extract (SP@MSNs) was established and assessed using diﬀerent structural and morphological analyses, primarily SEM, TEM, EDX, XRD, FTIR spectroscopy, BET, zeta size and potential analyses and TGA, followed by screening against normal and breast cancerous cells using the MTT assay. This biocompatible nanocomposite revealed optimal physicochemical properties regarding size, shape, surface charge, and chemistry, and it exhibited promising loading capacity (LC%) and encapsulation eﬃciency (EE%) scores of 78 . 07% and 98 .37%, respectively. SP@MSNs showed a 3 . 5-fold increase in antibreast cancer action (IC50 = 33.6 ± 0.32 mg mL−1) compared to Spirulina extract alone. MSNs enhanced the Spirulina compounds' stability, solubility, and cellular uptake, maximizing anticancer eﬃcacy. These ﬁndings reveal the signiﬁcance of the synergy between nanotechnology and network pharmacology to establish a multifaceted drug discovery framework and a high-precision delivery system for breast cancer therapy. Nevertheless, continued interdisciplinary research is crucial for bolstering its biological relevance.  \n1. Introduction  \nIn the view of the 2023 global cancer annual report, breast cancer continues to be one of the world's most preventable and  \naDepartment of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt. E-mail: [Dinaghallab6@gmail.com](Dinaghallab6@gmail.com); Dina.Ghalab@alexu. [edu.eg](edu.eg); Tel: +0201080919812  \nbBio-screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt  \ncCenter of Excellence for Drug Preclinical Studies (CE-DPS), Pharmaceutical and Fermentation Industry Development Center, City of Scienti􀀁c Research and Technological Applications (SRTA-City), New Burg El-Arab City, Alexandria, Egypt dResearch Projects Unit, Pharos University, Alexandria 21934, Egypt  \neFabrication Technology Research Department, Advanced Technology and New Materials Research Institute (ATNMRI), City of Scienti􀀁c Research and Technological Applications (SRTA-City), New Borg El-Arab, Alexandria 21934, Egypt  \ndeadly diseases among women, and its incidence rate continues to rise annually, even with the advancements in therapy.1 Despite revolutionary eﬀorts manifested by surgical resection, targeted chemotherapy, and immunotherapy to minimize such oncological disorders, the high recurrence rate and emergence of drug resistance during some phases of tumorigenesis, coupled with the lack of distinction of some conventiona","cbCaierMI0PjoPff","https://ap.wps.com/l/cbCaierMI0PjoPff","pdf",2594003,16,"English","# Introduction\n## Network pharmacology and mechanistic target identification\n## SP@MSNs preparation and characterization\n## Cytotoxicity assessment and comparative efficacy","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To systematically evaluate a mesoporous silica nanoparticle (MSNs)-Spirulina platensis nanohybrid for breast cancer treatment, including mechanistic investigation using pharmacological network analysis.\"},{\"question\":\"Which core target genes were identified through network pharmacology?\",\"answer\":\"AKT1, SRC, IGFR1, BCL-2, and EGFR were highlighted as core target genes associated with relevant cancer pathways and multi-wave mechanisms of Spirulina compounds.\"},{\"question\":\"How was the SP@MSNs nanohybrid prepared and characterized?\",\"answer\":\"SP@MSNs was formulated as a nanohybrid platform and characterized using structural and morphological analyses including SEM, TEM, EDX, XRD, FTIR, BET, zeta size/potential, and TGA.\"},{\"question\":\"How did SP@MSNs perform compared with Spirulina extract alone?\",\"answer\":\"SP@MSNs increased antibreast cancer activity by about 3.5-fold, with an IC50 value of 33.6 ± 0.32 mg mL−1, while MSNs improved stability, solubility, and cellular uptake.\"}]","Systematic evaluation of a novel mesoporous silica nanoparticles (MSNs)-Spirulina platensis nanohybrid for breast cancer treatment: mechanistic investigation via pharmacological network analysis | PDF",1790085223,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68452ebb7424b2ca5324eec9b4d4b1c8.webp",983,1287,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2214f4111e717c3d4e329b947586c3e3.webp",982,1286,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e117d25ab948ac95fef160ac3f6ca3c.webp",981,1284,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f627a3f163c106719b024488438cf81.webp",980,1283]